The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

The system was tested by (1) determining specificity and sensitivity in SSc cases and controls with scleroderma-like disorders ... fingertip lesions, telangiectasia, abnormal nailfold capillaries, ...

Scleroderma is classified as a rare, autoimmune, collagen-vascular disease of unknown etiology that can be difficult to diagnose and treat. Its onset can be insidious or rapid; the symptoms range ...

The signs and symptoms of scleroderma can be mistaken for any number of diseases, depending on the predominant symptom at the time of examination. Numerous referrals to specialists result in ...

“We have the first device to treat macular telangiectasia type 2, which has been through the clinical trial program, and the long-term results up to 9 years find that it is still relatively well ...

Back to Healio Macular telangiectasia type 2 is a progressive and relatively rare neurodegenerative disease of the macula that typically affects patients who are older than 40 years of age ...

Purpose: Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by arteriovenous malformations (AVM), mostly cutaneous and mucous (telangiectases), but also ...

1 Department of Rheumatology and Immunology, Qinzhou First People's Hospital, Qinzhou, Guangxi, China 2 Minda Hospital of Hubei Minzu University, Enshi, China Cell therapy is an emerging strategy for ...

The task force consisted of 32 SSc clinical experts from Europe and the USA, 2 patients nominated by the pan-European patient association for SSc (Federation of European Scleroderma Associations ...

The second patient was a 30 year old woman who had three episodes of paroxysmal left lip movement 4 weeks after child delivery; MRI showed capillary telangiectasia in the right corticonuclear pathway.